Skip to content
Buy This GLP
← Research
Evidence

Do GLP-1 Drugs Affect Blood Clot Risk After Surgery?

A matched hip replacement study found fewer cases of deep vein thrombosis in patients with prior GLP-1 prescriptions. The study could not determine cause and effect.

Editorial profile: Neil SandersBuy This GLP Editorial Team5 min read
Deep vein thrombosis within 90 days of hip replacementGLP-1 prescriptions1.6%matched controls3.0%Matched hip replacement cohort, 1,262 per groupAn observational study of primary hip replacement.

What the hip replacement study measured

Researchers used TriNetX records for adults who had a first total hip replacement between 2003 and 2023. Exposure meant at least three GLP-1 prescriptions in the year before surgery. Matching on demographics, medical conditions, and available lab results left 1,262 people per group. Prescription records could not confirm who took the medication close to the operation.[1]

Deep vein thrombosis (DVT) within 90 days was recorded in 1.6% of the GLP-1 group and 3.0% of matched controls (relative risk 0.53, 95% confidence interval 0.31 to 0.89). Hospital readmission was 1.1% and 2.8%, respectively (relative risk 0.40, 95% confidence interval 0.22 to 0.71). The study found no statistically significant differences in other 90-day outcomes or in five-year revision and joint-infection outcomes.[1]

Research on surgical wound healing tracks different outcomes. In this hip study, DVT was the only thromboembolic endpoint that differed significantly, and matching may have left differences between patients unaccounted for. The authors called for prospective research before drawing conclusions about clot risk.[1]

What other surgery studies measured

Four randomized trials of perioperative liraglutide in cardiac surgery enrolled 446 patients. The pooled mortality result was based on 1 death among 161 liraglutide patients and 3 among 160 controls (relative risk 0.42, 95% confidence interval 0.06 to 2.81). The wide interval leaves substantial uncertainty. A matched spinal-fusion study of 425 semaglutide users and 2,514 controls found no statistically significant difference in overall complications at 90 days or two years. These were different procedures and outcomes from the hip study.[2][3]

What to discuss before surgery

When planning GLP-1 treatment around surgery, tell the surgical and anesthesia teams which medication you take. Wegovy’s prescribing information describes rare reports of pulmonary aspiration under general anesthesia or deep sedation and says available data are insufficient to determine whether changing fasting instructions or briefly stopping the drug reduces that risk. Follow the instructions from your care team for the planned procedure.[4]

Frequently asked

Do GLP-1 drugs cause blood clots after surgery?
The matched hip replacement study cannot establish whether GLP-1 medications cause or prevent clots. It recorded 90-day deep vein thrombosis in 1.6% of the prescription group and 3.0% of matched controls.
What should I tell the surgical team?
Tell your surgeon and anesthesia team which GLP-1 medication you take before the procedure. The Wegovy label identifies aspiration as a separate concern under general anesthesia or deep sedation.

Sources

  1. [1] Diab AR, et al. (2026). Preoperative GLP-1 receptor agonist use and outcomes after total hip arthroplasty: a matched cohort study Hip International. PMID 42725550
  2. [2] Gamal I, et al. (2026). Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Cardiology in Review. PMID 42693519
  3. [3] Ng MK, Mastrokostas PG, Tabbaa A, Razi A, Johnson M, Said M (2026). Semaglutide Use Is Associated With Decreased Length of Stay and Hospital Costs in Patients Undergoing Anterior Lumbar Interbody Fusion: A Retrospective Cohort Study Orthopedics. PMID 41636429
  4. [4] Novo Nordisk (2026). Wegovy (semaglutide) prescribing information DailyMed, U.S. National Library of Medicine. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence